{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:04:38Z","timestamp":1761919478445,"version":"3.38.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T00:00:00Z","timestamp":1308787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002083","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T20:49:12Z","timestamp":1308862152000},"page":"e1002083","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":86,"title":["Predicting Binding to P-Glycoprotein by Flexible Receptor Docking"],"prefix":"10.1371","volume":"7","author":[{"given":"Elena","family":"Dolghih","sequence":"first","affiliation":[]},{"given":"Clifford","family":"Bryant","sequence":"additional","affiliation":[]},{"given":"Adam R.","family":"Renslo","sequence":"additional","affiliation":[]},{"given":"Matthew P.","family":"Jacobson","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,6,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.","volume":"84","author":"F Thiebaut","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","article-title":"The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox).","volume":"13","author":"G Szakacs","year":"2008","journal-title":"Drug Discov Today"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.","volume":"97","author":"AH Schinkel","year":"1996","journal-title":"J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter.","volume":"39","author":"SV Ambudkar","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: more than just drug efflux pumps.","volume":"10","author":"JI Fletcher","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/00498250801923855","article-title":"Role of transport proteins in drug discovery and development: a pharmaceutical perspective.","volume":"38","author":"A Ayrton","year":"2008","journal-title":"Xenobiotica"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1389200023337559","article-title":"Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.","volume":"3","author":"JH Hochman","year":"2002","journal-title":"Curr Drug Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","article-title":"Rational use of in vitro P-glycoprotein assays in drug discovery.","volume":"299","author":"JW Polli","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.107.017434","article-title":"In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.","volume":"36","author":"B Feng","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/ci700284p","article-title":"Significance analysis and multiple pharmacophore models for differentiating P-glycoprotein substrates.","volume":"47","author":"WX Li","year":"2007","journal-title":"J Chem Inf Model"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.","volume":"303","author":"KM Mahar Doan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2004.10.007","article-title":"Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier.","volume":"288","author":"Q Wang","year":"2005","journal-title":"Int J Pharm"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/jps.20035","article-title":"Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model.","volume":"93","author":"VK Gombar","year":"2004","journal-title":"J Pharm Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/mp050071a","article-title":"Computational models for identifying potential P-glycoprotein substrates and inhibitors.","volume":"3","author":"P Crivori","year":"2006","journal-title":"Mol Pharm"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.107.121525","article-title":"Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.","volume":"322","author":"SG Summerfield","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1432-1327.1998.2510252.x","article-title":"A general pattern for substrate recognition by P-glycoprotein.","volume":"251","author":"A Seelig","year":"1998","journal-title":"Eur J Biochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1073\/pnas.84.9.3004","article-title":"Expression of a full-length cDNA for the human \u201cMDR1\u201d gene confers resistance to colchicine, doxorubicin, and vinblastine.","volume":"84","author":"K Ueda","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1021\/bi00251a013","article-title":"Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.","volume":"33","author":"TW Loo","year":"1994","journal-title":"Biochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1997.00130.x","article-title":"Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.","volume":"250","author":"AB Shapiro","year":"1997","journal-title":"Eur J Biochem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/mol.62.6.1288","article-title":"Characterization of two pharmacophores on the multidrug transporter P-glycoprotein.","volume":"62","author":"A Garrigues","year":"2002","journal-title":"Mol Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/jm0255062","article-title":"A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein.","volume":"45","author":"JE Penzotti","year":"2002","journal-title":"J Med Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/ci0504317","article-title":"Combinatorial QSAR modeling of P-glycoprotein substrates.","volume":"46","author":"P de Cerqueira Lima","year":"2006","journal-title":"J Chem Inf Model"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1021\/ci700083n","article-title":"Identifying P-glycoprotein substrates using a support vector machine optimized by a particle swarm.","volume":"47","author":"J Huang","year":"2007","journal-title":"J Chem Inf Model"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jps.20449","article-title":"A topological substructural approach for the prediction of P-glycoprotein substrates.","volume":"95","author":"MA Cabrera","year":"2006","journal-title":"J Pharm Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1073\/pnas.94.20.10594","article-title":"Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.","volume":"94","author":"S Dey","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"50136","DOI":"10.1074\/jbc.M310448200","article-title":"Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites.","volume":"278","author":"TW Loo","year":"2003","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/mol.58.3.624","article-title":"Communication between multiple drug binding sites on P-glycoprotein.","volume":"58","author":"C Martin","year":"2000","journal-title":"Mol Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0925-4439(96)00008-7","article-title":"Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein.","volume":"1316","author":"S Ayesh","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.","volume":"323","author":"SG Aller","year":"2009","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"39706","DOI":"10.1074\/jbc.M308559200","article-title":"Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.","volume":"278","author":"TW Loo","year":"2003","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects.","volume":"49","author":"W Sherman","year":"2006","journal-title":"J Med Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.","volume":"49","author":"RA Friesner","year":"2006","journal-title":"J Med Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1021\/jp982533o","article-title":"Generalized born model based on a surface integral formulation.","volume":"102","author":"A Ghosh","year":"1998","journal-title":"J Phys Chem B"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/ci0502855","article-title":"Physics-based scoring of protein-ligand complexes: enrichment of known inhibitors in large-scale virtual screening.","volume":"46","author":"N Huang","year":"2006","journal-title":"J Chem Inf Model"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.","volume":"25","author":"SF Altschul","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.","volume":"47","author":"RA Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides.","volume":"105","author":"GA Kaminski","year":"2001","journal-title":"J Phys Chem B"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/ja00214a001","article-title":"The Opls Potential Functions for Proteins - Energy Minimizations for Crystals of Cyclic-Peptides and Crambin.","volume":"110","author":"WL Jorgensen","year":"1988","journal-title":"J Am Chem Soc"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","article-title":"On the role of the crystal environment in determining protein side-chain conformations.","volume":"320","author":"MP Jacobson","year":"2002","journal-title":"J Mol Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets.","volume":"36","author":"DS Wishart","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2006.10.007","article-title":"A primer on the mechanics of P-glycoprotein the multidrug transporter.","volume":"55","author":"M Hennessy","year":"2007","journal-title":"Pharmacol Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"D355","DOI":"10.1093\/nar\/gkp896","article-title":"KEGG for representation and analysis of molecular networks involving diseases and drugs.","volume":"38","author":"M Kanehisa","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.1021\/jm058198r","article-title":"Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K.","volume":"48","author":"JT Palmer","year":"2005","journal-title":"J Med Chem"},{"key":"ref44","first-page":"58","article-title":"Synthesis of N-protected alpha-Amino acids from N-(benzyloxycarbonyl)-L-serine via its beta-lactone: N-(benzyloxycarbonyl)-beta-(pyrazol-1-yl)-L-alanine.","volume":"Vol. 9","author":"SV Pansare","year":"1998","journal-title":"Organic Syntheses"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1021\/ja00310a058","article-title":"Conversion of Serine to Stereochemically Pure Beta-Substituted Alpha-Amino-Acids Via Beta-Lactones.","volume":"107","author":"LD Arnold","year":"1985","journal-title":"J Am Chem Soc"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"44332","DOI":"10.1074\/jbc.M208433200","article-title":"Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein.","volume":"277","author":"TW Loo","year":"2002","journal-title":"J Biol Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/joe.1.06096","article-title":"Thyroid hormone export from cells: contribution of P-glycoprotein.","volume":"185","author":"AM Mitchell","year":"2005","journal-title":"J Endocrinol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.108.149815","article-title":"Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1alpha,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer.","volume":"330","author":"J Fan","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0021-9258(19)85010-X","article-title":"Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus.","volume":"264","author":"CP Yang","year":"1989","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1006\/bbrc.2000.3554","article-title":"Cholesterol interaction with the daunorubicin binding site of P-glycoprotein.","volume":"276","author":"E Wang","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0026-895X(25)09793-7","article-title":"Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.","volume":"46","author":"JS Lee","year":"1994","journal-title":"Mol Pharmacol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"14073","DOI":"10.1021\/ja063076p","article-title":"Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides.","volume":"128","author":"T Rezai","year":"2006","journal-title":"J Am Chem Soc"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10822-007-9141-z","article-title":"An atomistic model of passive membrane permeability: application to a series of FDA approved drugs.","volume":"21","author":"C Kalyanaraman","year":"2007","journal-title":"J Comput Aided Mol Des"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:57:37Z","timestamp":1741273057000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002083"}},"subtitle":[],"editor":[{"given":"James M.","family":"Briggs","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,6,23]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002083","relation":{},"ISSN":["1553-7358"],"issn-type":[{"type":"electronic","value":"1553-7358"}],"subject":[],"published":{"date-parts":[[2011,6,23]]}}}